BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2020 8:10:05 AM | Browse: 717 | Download: 1842
 |
Received |
|
2020-08-06 13:15 |
 |
Peer-Review Started |
|
2020-08-06 13:16 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2020-10-18 02:19 |
 |
Revised |
|
2020-10-31 16:15 |
 |
Second Decision |
|
2020-11-06 09:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2020-11-09 00:58 |
 |
Articles in Press |
|
2020-11-09 00:58 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2020-11-14 02:13 |
 |
Typeset the Manuscript |
|
2020-12-10 02:13 |
 |
Publish the Manuscript Online |
|
2020-12-14 08:10 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Case Control Study |
Article Title |
Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Jie Yang, Ya-han Zhang, Jia-Wu Li, Ying-Yu Shi, Jia-Yan Huang, Yan Luo, Ji-Bin Liu and Qiang Lu |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
81571697 |
The Science and Technology Department of Sichuan Province |
2017SZ0003 and 2018FZ0044 |
|
Corresponding Author |
Qiang Lu, MD, Professor, Department of Medical Ultrasound, West China Hospital of Sichuan University, No. 37 Guoxue Xiang, Chengdu 610041, Sichuan Province, China. luqiang@scu.edu.cn |
Key Words |
Combined hepatocellular-cholangiocarcinoma; Contrast-enhanced ultrasound; Liver imaging reporting and data system; Sensitivity; Diagnosis; Liver neoplasms |
Core Tip |
The imaging features of combined hepatocellular-cholangiocarcinoma (CHC) are complicated due to its complex histopathological characteristics. In addition, biopsy may misguide the correct diagnosis of CHC due to sampling error or tissue insufficiency. This study investigated the diagnostic value of the contrast-enhanced ultrasound Liver Imaging Reporting and Data System classification in association with serological tumor markers in differentiating CHC from hepatocellular carcinoma and intrahepatic cholangiocarcinoma. The results showed that the combined diagnostic criteria had high specificity and negative predictive value but low sensitivity for the diagnosis of CHC. These findings could help radiologists and clinical investigators confidently exclude CHC lesions in the clinical setting. |
Publish Date |
2020-12-14 08:10 |
Citation |
Yang J, Zhang YH, Li JW, Shi YY, Huang JY, Luo Y, Liu JB, Lu Q. Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma. World J Gastroenterol 2020; 26(46): 7325-7337 |
URL |
https://www.wjgnet.com/1007-9327/full/v26/i46/7325.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v26.i46.7325 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345